A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer

被引：0
|
作者：
Ozge Gumusay
Laura A. Huppert
Mark Jesus M. Magbanua
Chiara A. Wabl
Michael Assefa
Amy Jo Chien
Michelle E. Melisko
Melanie C. Majure
Mark Moasser
John Park
Hope S. Rugo
机构：
[1] Acibadem University,Department of Medical Oncology, School of Medicine
[2] University of California San Francisco,Department of Laboratory Medicine
[3] Helen Diller Family Comprehensive Cancer Center,undefined
[4] UCSF,undefined
来源：
Breast Cancer Research and Treatment | 2024年 / 203卷
关键词：
Eribulin; Cyclophosphamide; Metastatic breast cancer; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：197 / 204
页数：7
相关论文
共 50 条
  • [41] Phase I study of docetaxel and cyclophosphamide in patients with advanced or recurrent breast cancer
    Tadao Shimizu
    Kohji Enomoto
    Shunsuke Haga
    Mamoru Fukuda
    Yuichi lino
    Tadashi lkeda
    Tetsuo Taguchi
    Breast Cancer, 2003, 10 (2) : 140 - 148
  • [42] Safety and pharmacokinetics of ramucirumab in combination with docetaxel in Japanese patients with locally advanced or metastatic breast cancer: a Phase Ib study
    Masuda, Norikazu
    Iwata, Hiroji
    Aogi, Kenjiro
    Xu, Yihuan
    Ibrahim, Ayman
    Gao, Ling
    Dalal, Rita
    Yoshikawa, Reigetsu
    Sasaki, Yasutsuna
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (12) : 1088 - 1094
  • [43] Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer
    Ardavanis, A
    Extra, JM
    Espié, M
    Cuvier, C
    Marty, M
    IN VIVO, 1998, 12 (05): : 559 - 562
  • [44] Lonidamine plus epirubicin and cyclophosphamide in advanced breast cancer. A phase II study
    Gardin, G
    Barone, C
    Nascimben, O
    Ianniello, G
    Sturba, F
    Contu, A
    Pronzato, P
    Rosso, R
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (01) : 176 - 177
  • [45] Eribulin in the treatment of patients with advanced breast cancer
    Lacko, Aleksandra
    ONCOLOGY IN CLINICAL PRACTICE, 2013, 9 (01): : 10 - 14
  • [46] Gene Alterations in Triple-Negative Breast Cancer Patients in a Phase I/II Study of Eribulin and Olaparib Combination Therapy
    Shimomura, Akihiko
    Yonemori, Kan
    Yoshida, Masayuki
    Yoshida, Teruhiko
    Yasojima, Hiroyuki
    Masuda, Norikazu
    Aogi, Kenjiro
    Takahashi, Masato
    Naito, Yoichi
    Shimizu, Satoru
    Nakamura, Rikiya
    Hamada, Akinobu
    Michimae, Hirofumi
    Hashimoto, Jun
    Yamamoto, Harukaze
    Kawachi, Asuka
    Shimizu, Chikako
    Fujiwara, Yasuhiro
    Tamura, Kenji
    TRANSLATIONAL ONCOLOGY, 2019, 12 (10): : 1386 - 1394
  • [47] Phase I study of combination therapy with weekly paclitaxel and cyclophosphamide for advanced or recurrent breast cancer
    Masuda, Norikazu
    Nakayama, Takahiro
    Yamamura, Jun
    Kamigaki, Shunji
    Taguchi, Tetsuya
    Hatta, Mai
    Sakamoto, Junichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (01) : 89 - 94
  • [48] Phase I study of combination therapy with weekly paclitaxel and cyclophosphamide for advanced or recurrent breast cancer
    Norikazu Masuda
    Takahiro Nakayama
    Jun Yamamura
    Shunji Kamigaki
    Tetsuya Taguchi
    Mai Hatta
    Junichi Sakamoto
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 89 - 94
  • [49] A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer
    Erica L. Mayer
    Nabihah Tayob
    Siyang Ren
    Jennifer J. Savoie
    David R. Spigel
    Howard A. Burris
    Paula D. Ryan
    Lyndsay N. Harris
    Eric P. Winer
    Harold J. Burstein
    Breast Cancer Research and Treatment, 2024, 204 : 123 - 132
  • [50] A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer
    Mayer, Erica L.
    Tayob, Nabihah
    Ren, Siyang
    Savoie, Jennifer J.
    Spigel, David R.
    Burris, Howard A.
    Ryan, Paula D.
    Harris, Lyndsay N.
    Winer, Eric P.
    Burstein, Harold J.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 204 (01) : 123 - 132
12345